Skip to main content

Morphology of Vestibular Aqueduct Linked to Meniere Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on March 8, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, March 8, 2024 -- Morphological characteristics of the vestibular aqueduct (VA) are associated with the occurrence of Meniere disease (MD), according to a study published online Feb. 17 in The Laryngoscope.

Yan Huang, M.D., from Beijing Friendship Hospital, and colleagues collected retrospective data from 34 patients (40 ears) diagnosed with MD who underwent temporal bone ultrahigh-resolution computed tomography (U-HRCT) with isotropic 0.05-mm resolution, magnetic resonance with gadolinium enhancement, and pure-tone audiometry; data were also included for 34 age- and sex-matched controls (68 ears) who underwent U-HRCT. VA patency was classified qualitatively as locally not shown, locally faintly shown, or clearly shown throughout (grades 1, 2, and 3, respectively). Differences in VA morphology were analyzed between the MD and control groups.

VA was classified as grades 1, 2, and 3 in 11, 17, and 12 ears and five, 26, and 37 ears in the MD and control groups, respectively, with a significant difference noted in patency between the groups. The researchers found that compared with the control group, the MD group had a significantly smaller width of the outer orifice and length of VA. Correlations were seen for both VA patency and length with the degree of endolymphatic hydrops in the cochlea and the vestibule. There was no difference noted between VA morphology and degree of hearing loss.

"Our results showed that the morphological characteristics of the VA, including a narrowed lumen and shortened length, may be related to MD, as well as the degree of endolymphatic hydrops," the authors write. "These findings may be beneficial for investigating the pathogenesis of MD from an anatomical perspective."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.